{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:39:43Z","timestamp":1793147983869,"version":"4.5.0"},"reference-count":112,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"unspecified","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Financial Support for open access publishing was provided by MED MAPS srl. This funder was not involved in the study design, the writing of the article or the decision to submit it for publication."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,7,11]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>In sarcoidosis, personalised strategies that consider the various phenotypes and endotypes of the disease have the potential to improve patient care. The \u2018treatable traits\u2019 (TT) approach offers a promising strategy that has already been proposed and implemented in several other chronic pulmonary diseases. In this review, we propose five distinct TT categories for patients with sarcoidosis: aetiological, lifestyle, pulmonary, extrapulmonary (systemic) and comorbidities.<\/jats:p>\n                  <jats:p>Despite the potential of this strategy, several challenges hinder its implementation. In addition, much of the knowledge on the definition and prevalence of TTs comes from single-centre studies. Creating international registries will enhance our understanding and provide more accurate data on these traits.<\/jats:p>\n                  <jats:p>TTs are dynamic and require continuous evaluation to effectively respond to changes caused by disease progression or treatment response. A multidisciplinary management approach is therefore crucial as sarcoidosis can impact multiple organs. Integrating primary care physicians into the management framework will improve overall patient care.<\/jats:p>\n                  <jats:p>Incorporating patient preferences into the TT strategy is vital for improving adherence to treatment. Additionally, using patient-reported outcome measures will provide valuable insights into the impact of treatment.<\/jats:p>\n                  <jats:p>While the TT approach is feasible in developed healthcare systems, challenges exist in resource-limited settings. Advancing patient-centred care towards 5P medicine involves addressing key TTs that meet the unique patient needs.<\/jats:p>\n                  <jats:p>Therefore, randomised controlled trials focused on TTs are needed. Our proposed TT strategy aims to enhance quality of life and outcomes for patients with sarcoidosis while increasing awareness of the importance of TTs among healthcare providers and advocacy groups.<\/jats:p>","DOI":"10.1136\/bmjresp-2025-003919","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:05:20Z","timestamp":1785323120000},"page":"e003919","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Treatable traits approach for personalised management of sarcoidosis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-7785","authenticated-orcid":false,"given":"Francesco","family":"Amati","sequence":"first","affiliation":[{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stainer","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia Corinna","family":"Morlacchi","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"},{"name":"Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco Francesco","family":"Rinaldo","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Cardiovascular and Thoracic Department, AOU Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"},{"name":"Medical Sciences Department, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Biondini","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy"},{"name":"Department of Medicine, University of Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"},{"name":"Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Solidoro","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Cardiovascular and Thoracic Department, AOU Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"},{"name":"Medical Sciences Department, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy"},{"name":"Department of Medicine, University of Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026072904051452000_13.1.e003919.1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026072904051452000_13.1.e003919.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101555"},{"key":"2026072904051452000_13.1.e003919.3","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000080"},{"key":"2026072904051452000_13.1.e003919.4","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/resp.13105","article-title":"Resolution rate of pulmonary sarcoidosis and its related factors in a Japanese population","volume":"22","author":"Hattori","year":"2017","journal-title":"Respirology"},{"key":"2026072904051452000_13.1.e003919.5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejim.2020.04.024","article-title":"Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients","volume":"77","author":"Rubio-Rivas","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2026072904051452000_13.1.e003919.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"2026072904051452000_13.1.e003919.7","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0145-2019"},{"key":"2026072904051452000_13.1.e003919.8","doi-asserted-by":"crossref","unstructured":"Freitag-Wolf S , Schupp J , Fischer A , et al . Genetic profiles of clinical features in sarcoidosis. ERS International Congress 2018 abstracts; September 15, 2018 doi:10.1183\/13993003.congress-2018.OA2160","DOI":"10.1183\/13993003.congress-2018.OA2160"},{"key":"2026072904051452000_13.1.e003919.9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCP.0000000000001102","article-title":"Big data in sarcoidosis","volume":"30","author":"Rivera","year":"2024","journal-title":"Curr Opin Pulm Med"},{"key":"2026072904051452000_13.1.e003919.10","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0146-2019"},{"key":"2026072904051452000_13.1.e003919.11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020390","article-title":"Comprehensive care for patients with sarcoidosis","volume":"9","author":"Moor","year":"2020","journal-title":"J Clin Med"},{"key":"2026072904051452000_13.1.e003919.12","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11061089","article-title":"Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes","volume":"11","author":"Saketkoo","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2026072904051452000_13.1.e003919.13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","article-title":"Misconceptions regarding symptoms of sarcoidosis","volume":"9","author":"Drent","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026072904051452000_13.1.e003919.14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026072904051452000_13.1.e003919.15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"key":"2026072904051452000_13.1.e003919.16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(23)00002-4","article-title":"Treatable traits in interstitial lung diseases: a call to action","volume":"11","author":"Amati","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026072904051452000_13.1.e003919.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01509-2019"},{"key":"2026072904051452000_13.1.e003919.18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"key":"2026072904051452000_13.1.e003919.19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12016-023-08969-x","article-title":"Treatable traits in systemic sclerosis","volume":"65","author":"Amati","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026072904051452000_13.1.e003919.20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/biomedicines12051047","article-title":"First report of the prevalence at baseline and after 1-year follow-up of treatable traits in interstitial lung diseases","volume":"12","author":"Amati","year":"2024","journal-title":"Biomedicines"},{"key":"2026072904051452000_13.1.e003919.21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad067"},{"key":"2026072904051452000_13.1.e003919.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00422","article-title":"SNP variants in major histocompatibility complex are associated with sarcoidosis susceptibility: a joint analysis in four European populations","volume":"8","author":"Wolin","year":"2017","journal-title":"Front Immunol"},{"key":"2026072904051452000_13.1.e003919.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00035213"},{"key":"2026072904051452000_13.1.e003919.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2011.10.012"},{"key":"2026072904051452000_13.1.e003919.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0585-3"},{"key":"2026072904051452000_13.1.e003919.26","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/oby.2010.1","article-title":"T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL\/6 mice","volume":"18","author":"Strissel","year":"2010","journal-title":"Obesity"},{"key":"2026072904051452000_13.1.e003919.27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020"},{"key":"2026072904051452000_13.1.e003919.28","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu045"},{"key":"2026072904051452000_13.1.e003919.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1099"},{"key":"2026072904051452000_13.1.e003919.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.10.003"},{"key":"2026072904051452000_13.1.e003919.31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01397-2017"},{"key":"2026072904051452000_13.1.e003919.32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.chest.2022.05.008","article-title":"The relationship of obesity and OSA to the development of sarcoidosis: a large retrospective case-control US Veterans Administration analysis","volume":"162","author":"Judson","year":"2022","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.chest.2022.07.019","article-title":"Obesity and sarcoidosis risk: an index under suspicion","volume":"162","author":"Cozier","year":"2022","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-021-01761-7","article-title":"FEV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients","volume":"21","author":"Frye","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026072904051452000_13.1.e003919.35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2026072904051452000_13.1.e003919.36","first-page":"124","article-title":"Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids","volume":"33","author":"Aggarwal","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026072904051452000_13.1.e003919.37","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0665"},{"key":"2026072904051452000_13.1.e003919.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.09.003"},{"key":"2026072904051452000_13.1.e003919.39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","article-title":"Association of medication adherence and clinical outcomes in sarcoidosis","volume":"158","author":"Sharp","year":"2020","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.40","doi-asserted-by":"publisher","DOI":"10.1007\/s13142-015-0315-2"},{"key":"2026072904051452000_13.1.e003919.41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/resp.12059","article-title":"Accuracy of patient self-report as a measure of inhaled asthma medication use","volume":"18","author":"Patel","year":"2013","journal-title":"Respirology"},{"key":"2026072904051452000_13.1.e003919.42","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014522982"},{"key":"2026072904051452000_13.1.e003919.43","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1513\/AnnalsATS.202011-1467OC","article-title":"Barriers to care among patients with sarcoidosis: a qualitative study","volume":"18","author":"Harper","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026072904051452000_13.1.e003919.44","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2013.790415"},{"key":"2026072904051452000_13.1.e003919.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.001"},{"key":"2026072904051452000_13.1.e003919.46","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-024-00381-y","article-title":"Change is in the air: key questions on the \u201cTreatable Traits\u201d model for chronic airway diseases in primary care","volume":"34","author":"Agusti","year":"2024","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026072904051452000_13.1.e003919.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2026072904051452000_13.1.e003919.48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2213-2600(23)00267-9","article-title":"High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study","volume":"12","author":"Desai","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026072904051452000_13.1.e003919.49","doi-asserted-by":"publisher","DOI":"10.1186\/1745-9974-9-9"},{"key":"2026072904051452000_13.1.e003919.50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00408-017-0040-3","article-title":"The assessment of cough in a sarcoidosis clinic using a validated instrument and a visual analog scale","volume":"195","author":"Judson","year":"2017","journal-title":"Lung"},{"key":"2026072904051452000_13.1.e003919.51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01369-2015"},{"key":"2026072904051452000_13.1.e003919.52","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12186088","article-title":"The symptoms of pulmonary sarcoidosis","volume":"12","author":"Judson","year":"2023","journal-title":"J Clin Med"},{"key":"2026072904051452000_13.1.e003919.53","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2012.747204"},{"key":"2026072904051452000_13.1.e003919.54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0873-2159(15)30498-0","article-title":"Airway responsiveness in sarcoidosis","volume":"11","author":"Carvalho","year":"2005","journal-title":"Rev Port Pneumol"},{"key":"2026072904051452000_13.1.e003919.55","doi-asserted-by":"crossref","first-page":"103123","DOI":"10.1016\/j.jaut.2023.103123","article-title":"Quality of life in sarcoidosis","volume":"149","author":"Moor","year":"2024","journal-title":"J Autoimmun"},{"key":"2026072904051452000_13.1.e003919.56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.545413","article-title":"Treatment of sarcoidosis: a multidisciplinary approach","volume":"11","author":"Gerke","year":"2020","journal-title":"Front Immunol"},{"key":"2026072904051452000_13.1.e003919.57","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of interstitial lung disease associated cough: CHEST guideline and expert panel report","volume":"154","author":"Birring","year":"2018","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.006"},{"key":"2026072904051452000_13.1.e003919.59","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2569"},{"key":"2026072904051452000_13.1.e003919.60","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025212"},{"key":"2026072904051452000_13.1.e003919.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.015"},{"key":"2026072904051452000_13.1.e003919.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105997"},{"key":"2026072904051452000_13.1.e003919.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"2026072904051452000_13.1.e003919.64","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026072904051452000_13.1.e003919.65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.hrtlng.2023.05.013","article-title":"Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls","volume":"61","author":"Bloem","year":"2023","journal-title":"Heart Lung"},{"key":"2026072904051452000_13.1.e003919.66","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0615"},{"key":"2026072904051452000_13.1.e003919.67","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0050OC"},{"key":"2026072904051452000_13.1.e003919.68","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00692-2018"},{"key":"2026072904051452000_13.1.e003919.69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ebiom.2019.10.050","article-title":"Endotype\u2013phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease","volume":"50","author":"Hoffmann-Vold","year":"2019","journal-title":"EBioMedicine"},{"key":"2026072904051452000_13.1.e003919.70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026072904051452000_13.1.e003919.71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00010209"},{"key":"2026072904051452000_13.1.e003919.72","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cyto.2012.12.016","article-title":"Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease","volume":"61","author":"Patterson","year":"2013","journal-title":"Cytokine"},{"key":"2026072904051452000_13.1.e003919.73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ccm.2023.08.011","article-title":"Fibrotic pulmonary sarcoidosis","volume":"45","author":"Nunes","year":"2024","journal-title":"Clin Chest Med"},{"key":"2026072904051452000_13.1.e003919.74","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.174.6.1741751"},{"key":"2026072904051452000_13.1.e003919.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.08.012"},{"key":"2026072904051452000_13.1.e003919.76","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2026072904051452000_13.1.e003919.77","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0165-2021"},{"key":"2026072904051452000_13.1.e003919.78","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017"},{"key":"2026072904051452000_13.1.e003919.79","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","article-title":"Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension","volume":"9","author":"Parikh","year":"2019","journal-title":"Sci Rep"},{"key":"2026072904051452000_13.1.e003919.80","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chest.2021.07.2162","article-title":"Riociguat for sarcoidosis-associated pulmonary hypertension: results of a 1-year double-blind, placebo-controlled trial","volume":"161","author":"Baughman","year":"2022","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.81","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1766"},{"key":"2026072904051452000_13.1.e003919.82","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.851352"},{"key":"2026072904051452000_13.1.e003919.83","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"2026072904051452000_13.1.e003919.84","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001240"},{"key":"2026072904051452000_13.1.e003919.85","first-page":"285","article-title":"The frequency of diastolic dysfunction in patients with sarcoidosis and it\u2019s relationship with HLA DRB1* alleles","volume":"36","author":"Ozyilmaz","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026072904051452000_13.1.e003919.86","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","article-title":"Management of cardiac sarcoidosis","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072904051452000_13.1.e003919.87","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"2026072904051452000_13.1.e003919.88","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(70)90054-8"},{"key":"2026072904051452000_13.1.e003919.89","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/07853890.2022.2063375","article-title":"Comorbidities of sarcoidosis","volume":"54","author":"Tana","year":"2022","journal-title":"Ann Med"},{"key":"2026072904051452000_13.1.e003919.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.005"},{"key":"2026072904051452000_13.1.e003919.91","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","article-title":"Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners","volume":"196","author":"Moor","year":"2018","journal-title":"Lung"},{"key":"2026072904051452000_13.1.e003919.92","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00002512"},{"key":"2026072904051452000_13.1.e003919.93","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.2.372"},{"key":"2026072904051452000_13.1.e003919.94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS)","volume":"9","author":"de Vries","year":"2004","journal-title":"British J Health Psychol"},{"key":"2026072904051452000_13.1.e003919.95","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/10547738231182550","article-title":"Performance of PROMIS measures to assess fatigue and sleep symptom severity among African American patients newly diagnosed with obstructive sleep apnea","volume":"32","author":"Giordano","year":"2023","journal-title":"Clin Nurs Res"},{"key":"2026072904051452000_13.1.e003919.96","first-page":"235","article-title":"The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis","volume":"22","author":"Wagner","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026072904051452000_13.1.e003919.97","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(22)00387-3","article-title":"Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial","volume":"11","author":"Kahlmann","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026072904051452000_13.1.e003919.98","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02223-2019"},{"key":"2026072904051452000_13.1.e003919.99","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00574-2017"},{"key":"2026072904051452000_13.1.e003919.100","doi-asserted-by":"crossref","unstructured":"Caffarelli C , Cameli P , Al Refaie A , et al . Bone fragility and sarcoidosis: an underestimated relationship. Front Med 2022;9. doi:10.3389\/fmed.2022.1026028","DOI":"10.3389\/fmed.2022.1026028"},{"key":"2026072904051452000_13.1.e003919.101","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.chest.2022.06.013","article-title":"Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis","volume":"162","author":"Marinescu","year":"2022","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.102","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","article-title":"Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases","volume":"153","author":"De Sadeleer","year":"2018","journal-title":"Chest"},{"key":"2026072904051452000_13.1.e003919.103","doi-asserted-by":"crossref","first-page":"17534666251323487","DOI":"10.1177\/17534666251323487","article-title":"Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion","volume":"19","author":"Amati","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"2026072904051452000_13.1.e003919.104","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00141-2018","article-title":"Sarcoidosis: patient treatment priorities","volume":"4","author":"Baughman","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026072904051452000_13.1.e003919.105","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202646"},{"key":"2026072904051452000_13.1.e003919.106","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.5.9704069"},{"key":"2026072904051452000_13.1.e003919.107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humimm.2018.05.007","article-title":"A sarcoidosis clinician\u2019s perspective of MHC functional elements outside the antigen binding site","volume":"80","author":"Judson","year":"2019","journal-title":"Hum Immunol"},{"key":"2026072904051452000_13.1.e003919.108","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00169413"},{"key":"2026072904051452000_13.1.e003919.109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cei.12808","article-title":"Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis","volume":"185","author":"Verwoerd","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2026072904051452000_13.1.e003919.110","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17895","article-title":"A roadmap for empowering cardiovascular disease patients: a 5P-Medicine approach and technological integration","volume":"12","author":"Denysyuk","year":"2024","journal-title":"PeerJ"},{"key":"2026072904051452000_13.1.e003919.111","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.3390\/s21216986","article-title":"Mobile 5P-medicine approach for cardiovascular patients","volume":"21","author":"Pires","year":"2021","journal-title":"Sensors"},{"key":"2026072904051452000_13.1.e003919.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2012.03.004"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:05:38Z","timestamp":1785323138000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjresp-2025-003919"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003919","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}